Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...

An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

The global laser-assisted ENT surgery market Share is projected to grow from US$ 254.14 million in 2023 to US$ 513.78 million by 2031, with a CAGR of 9.2%. The growth is fueled by the increasing ...

The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

CHENNAI: It’s surprising how many of us struggle with breathing — even though it is the most natural thing to do. But congestion, snoring, allergies, or structu ...

In fact, according to data from the US Small Business Administration, 99.9% of all businesses in the US qualify as small. That's why some big CRM players are reacting accordingly.

A small tablet can work just as well as (or even better than) larger ones, especially when it comes to lugging one around between classes or in your work bag on your commute. When you're on the ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...